SYRA
Syra Health Corp.0.0750
+0.0050+7.14%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
895.44KP/E (TTM)
-Basic EPS (TTM)
-0.08Dividend Yield
0%Recent Filings
10-K
FY2025 results
Syra Health posted FY2025 revenue of $7.2M, down 9% y/y from $8.0M, yet slashed net loss to $0.9M from $3.8M through cost discipline. Population health exploded to $5.3M (up 157% y/y), offsetting a 68% drop in workforce staffing to $1.9M amid FSSA contract renewals at lower value; gross margins leaped to 34% from 21%. Q4 saw Syrenity app launch, signaling behavioral health momentum, while operating cash burn improved sharply. Cash ended at $1.6M with $2.1M working capital. Government spending pauses threaten quarterly awards. Customer concentration burns.
8-K
157% population health growth
Syra Health reported FY2025 results on March 12, 2026, with population health revenue surging 157% to $5.3M despite total revenue dipping 9% to $7.2M from federal funding cuts. Net loss plunged 76% to ($896K), EPS hit ($0.08) from ($0.50), gross margin rose to 34.4%, and operating expenses fell 37% to $3.4M. Cash stands at $1.6M, debt-free. Targets profitability by year-end 2026.
8-K
Syra names new CEO Alexander
Syra Health appointed Gregory R. Alexander as CEO on December 15, 2025, effective January 5, 2026, with a $251,000 base salary, 30% target bonus, 110,537 RSUs, 257,920 stock options, and 368,458 PSUs tied to performance. The deal includes 6-month severance without cause, accelerated vesting on change of control, plus non-compete. New leader eyes growth.
8-K
Class B transfer rules eased
Syra Health amended its Certificate of Incorporation on November 18, 2025, effective immediately, deleting the automatic Class B conversion upon stockholder death and expanding permitted transfers to immediate family, heirs, successors, and assigns—changes approved by stockholders on November 14. This boosts Class B share liquidity. Amendment filed with Delaware.
8-K
Annual meeting results disclosed
Syra Health held its annual meeting on November 14, 2025, electing five directors—Priya Prasad, Dr. Vijayapal R. Reddy, Dr. Ketan Paranjape, Dr. Avutu S. Reddy, and Radhika Mereddy—despite significant abstentions topping 4.5M votes each. Shareholders ratified M&K CPAs as auditors and approved two charter amendments easing Class B stock transfer rules to family and heirs. Governance intact.
IPO
Website
Employees
Sector
Industry
CON
Concentra Group Holdings Parent
19.55-0.33
CYH
Community Health Systems, Inc.
3.25+0.03
EHC
Encompass Health Corporation
108.01+0.42
HCA
HCA Healthcare, Inc.
469.79-7.19
HLYK
HealthLynked Corp.
1.67-0.22
LFST
LifeStance Health Group, Inc.
6.88-0.04
NUTX
Nutex Health Inc.
171.72-4.06
SRXH
SRX Health Solutions, Inc.
0.38+0.07
UHS
Universal Health Services, Inc.
222.64-1.23
WHTCF
Well Health Technologies Corp.
2.89+0.03